Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Moberg Pharma Major Shareholding Notification 2011

Jun 23, 2011

3174_iss_2011-06-23_caa63d5f-798d-418d-aaf2-16b2cbc9ab4c.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Moberg Pharma AB (publ)

Holder

Avanza Bank Holding AB

Instrument

Instrument Aktier
Before the transaction
Shares 4,075,291
Voting rights 4,075,291
Transaction
Reason for major shareholding notification Share loan
Date 22/06/2011
Limit for number of shares 25 %
Limit for number of votes 25 %
After the transaction
Quantity
Shares 2,144,694
Directly held voting rights 0
Indirectly held voting rights 2,144,694
Percentage
Directly held shares 23.62 %
Directly held voting rights 0 %
Indirectly held voting rights 23.62 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares

Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3

- Physically settled

  • Cash settled

Total

Group total holdings

Voting rights 2,144,694 Percentage of voting rights 23.62

Notes (other relevant informations according to law)

Flaggningen avser tillbakalämnande av 1 929 352 aktier med anledning aktielån i samband med nyemission i Moberg Derma AB där Avanza Bank AB har agerat emissionsinstitut. 440 502 av kvarvarande aktier innehas av Försäkringsaktiebolaget Avanza Pension vilket, liksom Avanza Bank AB, är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Aktierna som innehas av Försäkringsaktiebolaget Avanza Pension grundas på försäkringskundernas egna investeringsbeslut via depåfullmakt. Resterande av kvarvarande aktier utgörs av ytterligare ett aktielån med anledning av tidigare nämnd emission.

Published

23/06/2011 13:57

Contact

Name Caroline Pettersson

Phone 08-56225123 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25